Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
CSE:NOVO B
Price:
850.6 DKK
-2.58%
Market Closed
Updated:
May 5, 2024
Novo Nordisk A/S
Interest Income Expense
|
Novo Nordisk A/S
Interest Income Expense Peer Comparison
Comparables:
HLUN A
ALK B
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novo Nordisk A/S
CSE:NOVO B
|
Interest Income Expense
kr2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
39%
|
CAGR 10-Years
8%
|
|
|
H Lundbeck A/S
CSE:HLUN A
|
Interest Income Expense
-kr149m
|
CAGR 3-Years
-99%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ALK-Abello A/S
CSE:ALK B
|
Interest Income Expense
-kr19m
|
CAGR 3-Years
25%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Interest Income Expense?
Interest Income Expense
2.3B
DKK
2.3B
DKK
Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Interest Income Expense amounts to 2.3B DKK.
What is Novo Nordisk A/S's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
8%
8%
You don't have any saved screeners yet
